NL190746B - Hydrodynamically balanced delayed release active ingredient pharmaceutical preparation. - Google Patents

Hydrodynamically balanced delayed release active ingredient pharmaceutical preparation.

Info

Publication number
NL190746B
NL190746B NLAANVRAGE8203343,A NL8203343A NL190746B NL 190746 B NL190746 B NL 190746B NL 8203343 A NL8203343 A NL 8203343A NL 190746 B NL190746 B NL 190746B
Authority
NL
Netherlands
Prior art keywords
active ingredient
pharmaceutical preparation
delayed release
release active
ingredient pharmaceutical
Prior art date
Application number
NLAANVRAGE8203343,A
Other languages
Dutch (nl)
Other versions
NL190746C (en
NL8203343A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL8203343A publication Critical patent/NL8203343A/en
Publication of NL190746B publication Critical patent/NL190746B/en
Application granted granted Critical
Publication of NL190746C publication Critical patent/NL190746C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8203343A 1981-09-14 1982-08-26 Hydrodynamically balanced delayed release active ingredient pharmaceutical preparation. NL190746C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14
US30149881 1981-09-14

Publications (3)

Publication Number Publication Date
NL8203343A NL8203343A (en) 1983-04-05
NL190746B true NL190746B (en) 1994-03-01
NL190746C NL190746C (en) 1994-08-01

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203343A NL190746C (en) 1981-09-14 1982-08-26 Hydrodynamically balanced delayed release active ingredient pharmaceutical preparation.

Country Status (11)

Country Link
JP (1) JPS5857315A (en)
AT (1) AT385199B (en)
BE (1) BE894376A (en)
BG (1) BG60526B2 (en)
CH (1) CH652025A5 (en)
DE (1) DE3232873A1 (en)
FR (1) FR2512676B1 (en)
GB (1) GB2105590B (en)
IT (1) IT1158048B (en)
MX (1) MX9203173A (en)
NL (1) NL190746C (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (en) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd Medicinal drug and its preparation
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (en) * 1986-08-26 1989-12-11 Lejus Medical Ab A MULTIPLE-UNIT DOS COMPOSITION OF L-DOPA
DE3642668A1 (en) * 1986-12-13 1988-06-23 Kamprad Joachim Painkillers for people
DE3875716D1 (en) * 1987-12-31 1992-12-10 Asta Medica Ag SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLETS.
DE69017915T2 (en) * 1989-10-26 1995-07-27 Nippon Shinyaku Co Ltd PREPARATION FOR THE STOMACH.
DE4101873C2 (en) 1991-01-23 1993-12-09 Isis Pharma Gmbh Orally administrable drug form for the treatment of central dopamine deficiency states
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (en) * 1992-11-30 1992-11-30 Christer Nystroem DISPERSA SYSTEM MEDICINAL PRODUCT
AU8000494A (en) * 1993-10-29 1995-05-22 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
DE69423643T2 (en) * 1993-10-29 2000-09-07 R.P. Scherer Corp., Troy Foaming gelatin capsule filling
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
AU2003282603A1 (en) * 2002-10-11 2004-05-04 Depomed Development Ltd Gastro-retentive levodopa delivery form
DE102004039196B4 (en) 2004-08-12 2008-07-31 Dr.Kamprad Kg New formulation for L-tryptophan
DE102010023828A1 (en) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmaceutical preparation containing entacapone, levodopa and carbidopa
DE102014003744A1 (en) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Product for oral administration to humans or animals with microstructured encapsulated ingredients, and apparatus for making such a product, and method of making the same
DE102022103658A1 (en) 2022-02-16 2023-08-17 Joachim Kamprad Drug composition containing L-tryptophan (L-Try) and L-5-hydroxytryptophan (5-HTP) and a peripheral degradation inhibitor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (en) * 1961-06-16 1966-03-31 Hoffmann La Roche Process for the preparation of substituted hydrazines
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (en) * 1972-02-14 1973-08-23 Hoffmann La Roche PHARMACEUTICAL PREPARATION
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Also Published As

Publication number Publication date
CH652025A5 (en) 1985-10-31
FR2512676A1 (en) 1983-03-18
GB2105590B (en) 1985-05-30
NL190746C (en) 1994-08-01
FR2512676B1 (en) 1987-01-23
MX9203173A (en) 1992-07-01
DE3232873A1 (en) 1983-03-31
NL8203343A (en) 1983-04-05
JPS5857315A (en) 1983-04-05
BE894376A (en) 1983-03-14
AT385199B (en) 1988-02-25
ATA341582A (en) 1987-08-15
IT8223147A0 (en) 1982-09-07
BG60526B2 (en) 1995-07-28
GB2105590A (en) 1983-03-30
IT1158048B (en) 1987-02-18
JPH0341447B2 (en) 1991-06-24

Similar Documents

Publication Publication Date Title
NL190746C (en) Hydrodynamically balanced delayed release active ingredient pharmaceutical preparation.
NL300007I1 (en) Preparation for the controlled release of an active substance.
NO801863L (en) PHARMACEUTICAL PREPARATIONS.
NL193218B (en) Method for the preparation of stainless steel.
NL930039I2 (en) Derivatives of cis, endo-2-azabicyclo- (3,3,0) -octane-3-carboxylic acid, process for the preparation thereof, agents containing these substances and their use.
NL192430B (en) Pharmaceutical preparation for delayed administration of potassium.
NL193907B (en) Basic ether and pharmaceutical composition containing the basic ether as the active ingredient.
NL189071C (en) COSMETIC PREPARATION.
NL187894C (en) CONTRAST PREPARATION FOR ANGIOGRAPHY.
ES514887A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF PIRIDAZINE.
FI822187L (en) PHARMACEUTICAL PREPARATION
ES515375A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 3-PIRIDILO AND 2-PIRACINILO.
NL187485C (en) PROSTAGLANDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATION.
NL7903725A (en) PHARMACEUTICAL REGULATED RELEASE DOSING COMPONENT.
NL184833C (en) 2-SUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
ES517030A0 (en) PROCEDURE FOR THE PREPARATION OF EBURNAMONINE DERIVATIVES.
NL7901241A (en) NEW SUBSTITUTED 2-PHENYLIMINO IMIDAZOLIDINES, THEIR ACID ADDITION SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND METHOD FOR THE PREPARATION THEREOF
NL187397C (en) PHARMACEUTICAL PREPARATIONS, 20,21-DINORO-BURNAMENINE COMPOUNDS THEREFOR AND METHOD FOR THEIR PREPARATION.
ES517427A0 (en) PROCEDURE FOR THE PREPARATION OF TRIAMINE TRIOXIDES.
ES519351A0 (en) PROCEDURE FOR THE PREPARATION OF BENZOTRIAZOLES.
NL7902993A (en) NEW ISOQUEINOLINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE NEW ISOQUEINOLINE DERIVATIVES.
NL7800097A (en) IMIDAZOLE DERIVATIVES AND METHODS FOR THEIR PREPARATION AND APPLICATION.
DZ276A1 (en) Pharmaceutical preparations.
MC1371A1 (en) PHARMACEUTICAL PREPARATIONS
ES514394A0 (en) "PROCEDURE FOR THE PREPARATION OF METHYL TERCI-BUTILETER OR ETILTERCI-BUTILETER".

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BT A notification was added to the application dossier and made available to the public
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOFFMANN-LA ROCHE AG. F. -

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20020826